1 |
Lemos JA, Palmer SR, Zeng L, et al. The biology of Streptococcus mutans [J]. Microbiol Spectr, 2019, 7(1): 10.
|
2 |
Matsumoto-Nakano M. Role of Streptococcus mutans surface proteins for biofilm formation[J]. Jpn Dent Sci Rev, 2018, 54(1): 22-29.
|
3 |
Featherstone JD. The science and practice of caries prevention[J]. J Am Dent Assoc, 2000, 131(7): 887-899.
|
4 |
Anderson MH. Changing paradigms in caries management[J]. Curr Opin Dent, 1992, 2: 157-162.
|
5 |
Cui T, Luo W, Xu L, et al. Progress of antimicrobial discovery against the major cariogenic pathogen Streptococcus mutans [J]. Curr Issues Mol Biol, 2019, 32: 601-644.
|
6 |
Liao Y, Brandt BW, Li J, et al. Fluoride resistance in Streptococcus mutans: a mini review[J]. J Oral Microbiol, 2017, 9(1): 1344509.
|
7 |
Patel HK, Bihani T. Selective estrogen receptor modulators (SERMs) and selective estrogen receptor degraders (SERDs) in cancer treatment[J]. Pharmacol Ther, 2018, 186: 1-24.
|
8 |
Baez-Jurado E, Rincón-Benavides MA, Hidalgo-Lanussa O, et al. Molecular mechanisms involved in the protective actions of selective estrogen receptor modulators in brain cells[J]. Front Neuroendocrinol, 2019, 52: 44-64.
|
9 |
Wong SK, Mohamad NV, Jayusman PA, et al. The use of selective estrogen receptor modulators on bone health in men[J]. Aging Male, 2019, 22(2): 89-101.
|
10 |
Cieplik F, Kara E, Muehler D, et al. Antimicrobial efficacy of alternative compounds for use in oral care toward biofilms from caries-associated bacteria in vitro [J]. Microbiologyopen, 2019, 8(4): e00695.
|
11 |
Garg A, Singh B, Sharma R, et al. Selective estrogen receptor modulators (SERMs): mechanistic insights aga-inst microbial infections[J]. Curr Mol Med, 2020, 20(2): 102-115.
|
12 |
Helo S, Wynia B, McCullough A. “Cherchez La Femme”: modulation of estrogen receptor function with selective modulators: clinical implications in the field of urology[J]. Sex Med Rev, 2017, 5(3): 365-386.
|
13 |
van Opijnen T, Lazinski DW, Camilli A. Genome-wide fitness and genetic interactions determined by Tn-seq, a high-throughput massively parallel sequencing method for microorganisms[J]. Curr Protoc Mol Biol, 2014, 106: 7.16.1-7.16.24.
|
14 |
Haydari M, Bardakci AG, Koldsland OC, et al. Comparing the effect of 0.06%-, 0.12% and 0.2% chlorhexidine on plaque, bleeding and side effects in an experimental gingivitis model: a parallel group, double masked randomized clinical trial[J]. BMC Oral Health, 2017, 17(1): 118.
|
15 |
Nonami K, Saitoh S, Nishimura-Danjobara Y, et al. Ch-lorhexidine possesses unique cytotoxic actions in rat thymic lymphocytes: its relation with electrochemical pro-perty of membranes[J]. Environ Toxicol Pharmacol, 2016, 48: 17-21.
|
16 |
Farha MA, Czarny TL, Myers CL, et al. Antagonism screen for inhibitors of bacterial cell wall biogenesis uncovers an inhibitor of undecaprenyl diphosphate synthase[J]. Proc Natl Acad Sci U S A, 2015, 112(35): 11048-11053.
|
17 |
El Arbi M, Théolier J, Pigeon P, et al. Antibacterial properties and mode of action of new triaryl butene citrate compounds[J]. Eur J Med Chem, 2014, 76: 408-413.
|
18 |
Luxo C, Jurado AS, Madeira VM, et al. Tamoxifen induces ultrastructural alterations in membranes of Bacillus Stearothermophilus [J]. Toxicol In Vitro, 2003, 17(5/6): 623-628.
|
19 |
Cruz Silva MM, Madeira VM, Almeida LM, et al. Hydroxytamoxifen interaction with human erythrocyte mem-brane and induction of permeabilization and subsequent hemolysis[J]. Toxicol In Vitro, 2001, 15(6): 615-622.
|
20 |
Cruz Silva MM, Madeira VM, Almeida LM, et al. Hemolysis of human erythrocytes induced by tamoxifen is related to disruption of membrane structure[J]. Biochim Biophys Acta, 2000, 1464(1): 49-61.
|
21 |
Practice Committee of the American Society for Reproductive Medicine. Use of clomiphene citrate in infertile women: a committee opinion[J]. Fertil Steril, 2013, 100(2): 341-348.
|
22 |
Schwartz LB, Brezinski A, Laufer N. The effect of clomiphene citrate isomers on human granulosa-lutein cells in culture[J]. Gynecol Endocrinol, 1993, 7(4): 229-233.
|
23 |
Taras TL, Wurz GT, Linares GR, et al. Clinical pharmacokinetics of toremifene[J]. Clin Pharmacokinet, 2000, 39(5): 327-334.
|
24 |
Kapoor A, Malhotra R, Grover V, et al. Systemic antibiotic therapy in periodontics[J]. Dent Res J (Isfahan), 2012, 9(5): 505-515.
|
25 |
Gerits E, Defraine V, Vandamme K, et al. Repurposing toremifene for treatment of oral bacterial infections[J]. Antimicrob Agents Chemother, 2017, 61(3): e01846-16.
|
26 |
Sedlacek MJ, Walker C. Antibiotic resistance in an in vitro subgingival biofilm model[J]. Oral Microbiol Immunol, 2007, 22(5): 333-339.
|
27 |
Montoya MC, Krysan DJ. Repurposing estrogen receptor antagonists for the treatment of infectious disease[J]. mBio, 2018, 9(6): e02272-18.
|
28 |
Odom AR. The triphenylethylenes, a novel class of antifungals[J]. mBio, 2014, 5(3): e01126-14.
|